Central role of hemoglobin degradation in mechanisms of action of 4- aminoquinolines, quinoline methanols, and phenanthrene methanols

Mathirut Mungthin, Patrick G. Bray, Robert G. Ridley, Steve Ward

Research output: Contribution to journalArticlepeer-review

88 Citations (Scopus)

Abstract

We have used a specific inhibitor of the malarial aspartic proteinase plasmepsin I and a nonspecific cysteine proteinase inhibitor to investigate the importance of hemoglobin degradation in the mechanism of action of chloroquine, amodiaquine, quinine, mefloquine (MQ), halofantrine, and primaquine. Both proteinase inhibitors antagonized the antiparasitic activity of all drugs tested with the exception of primaquine. An inhibitor of plasmepsin I, Ro40-4388, reduced the incorporation of radiolabelled chloroquine and quinine into malarial pigment by 95%, while causing a 70% reduction in the incorporation of radiolabelled MQ. Cysteine proteinase inhibitor E64 reduced the incorporation of chloroquine and quinine into malarial pigment by 60 and 40%, respectively. This study provides definitive support for the central role of hemoglobin degradation in the mechanism of action of the 4-aminoquinolines and the quinoline and phenanthrene methanol antimalarials.
Original languageEnglish
Pages (from-to)2973-2977
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume42
Issue number11
DOIs
Publication statusPublished - 1 Nov 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Central role of hemoglobin degradation in mechanisms of action of 4- aminoquinolines, quinoline methanols, and phenanthrene methanols'. Together they form a unique fingerprint.

Cite this